Home > People > Our Team > Steven Dyson

Steven Dyson



Dr. Steven Dyson is a Partner in the Healthcare team and is based in London. He joined Apax Partners in 2000 and has both led and participated in a number of key deals including Rodenstock, Candela, Unilabs, Vyaire Medical, Neuraxpharm, Acelity (formerly KCI), GENEX, Capio, and Zeneus Pharma. 

Prior to joining Apax Partners, Steven was a consultant with McKinsey & Company.

Steven holds a BA in Biochemistry from Oxford University and a PhD in Developmental Biology from Cambridge University.


Steven serves as a director and board member to Rodenstock, Healthium MedTech, Candela, Unilabs and Vyaire Medical. He previously served on the boards of Acelity, Capio and Genex.

Living our values

“Arriving at Apax as a scientist and imagining a future devoted to biotech investing, I faced a career crossroads early on when Apax pivoted from venture capital to private equity. I faced a steep learning curve and had a short window in which to prove myself to the organisation. Having successfully embraced healthcare buy-outs and personally finding them highly fulfilling, my watchwords are “learn, adapt and grow.””

Contact information

+44 20 7872 6300





Steven's Story

Steven joined Apax at the turn of the Millennium, drawn by the Firm’s sector specialisation, which enabled him to pursue his passion for healthcare and the opportunity to work with the most talented management teams. He continues to be inspired by the opportunity to back companies bringing life-changing products and services to patients, whilst creating value for all stakeholders.